Peptide-nucleic acid-mediated enriched polymerase chain reaction as a key point for non-invasive prenatal diagnosis of β-thalassemia
暂无分享,去创建一个
M. Ferrari | S. Galbiati | L. Cremonesi | G. Restagno | L. Sbaiz | C. Curcio | M. Travi | A. Ferrari | M. Smid | B. Foglieni | F. Pasi
[1] G. Ferrero,et al. Integrated strategy for fast and automated molecular characterization of genes involved in craniosynostosis. , 2007, Clinical chemistry.
[2] Y. Li,et al. Non‐invasive prenatal detection of achondroplasia in size‐fractionated cell‐free DNA by MALDI‐TOF MS assay , 2007, Prenatal diagnosis.
[3] G. Patrinos,et al. An Overview of Current Microarray-Based Human Globin Gene Mutation Detection Methods , 2007, Hemoglobin.
[4] M. Ferrari,et al. Different Approaches for Noninvasive Prenatal Diagnosis of Genetic Diseases Based on PNA‐Mediated Enriched PCR , 2006, Annals of the New York Academy of Sciences.
[5] M. Cazzola,et al. Microelectronic DNA chip for hereditary hyperferritinemia cataract syndrome, a model for large‐scale analysis of disorders of iron metabolism , 2006, Human mutation.
[6] S. Hober,et al. Pyrosequencing: history, biochemistry and future. , 2006, Clinica chimica acta; international journal of clinical chemistry.
[7] Y. Li,et al. Detection of paternally inherited fetal point mutations for beta-thalassemia using size-fractionated cell-free DNA in maternal plasma. , 2005, JAMA.
[8] C. Ding,et al. MS analysis of single-nucleotide differences in circulating nucleic acids: Application to noninvasive prenatal diagnosis. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[9] M. Ferrari,et al. Feasibility Study for a Microchip‐Based Approach for Noninvasive Prenatal Diagnosis of Genetic Diseases , 2004, Annals of the New York Academy of Sciences.
[10] Laura Cremonesi,et al. Beta-thalassemia microelectronic chip: a fast and accurate method for mutation detection. , 2004, Clinical chemistry.
[11] M. Ferrari,et al. No evidence of fetal DNA persistence in maternal plasma after pregnancy , 2003, Human Genetics.
[12] Marco Seri,et al. Analysis of clinically relevant single-nucleotide polymorphisms by use of microelectronic array technology. , 2002, Clinical chemistry.
[13] F. Schwarz,et al. Design and use of a peptide nucleic acid for detection of the heteroplasmic low-frequency mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS) mutation in human mitochondrial DNA. , 2002, Clinical chemistry.
[14] Mostafa Ronaghi,et al. Pyrosequencing™: An accurate detection platform for single nucleotide polymorphisms , 2002, Human mutation.
[15] L. Poon,et al. Clinical Chemistry 47:9 1607–1613 (2001) Molecular Diagnostics and Genetics Effects of Blood-Processing Protocols on Fetal and Total DNA Quantification in Maternal Plasma , 2001 .
[16] P. Nielsen. Peptide nucleic acid (PNA) , 1999 .
[17] I. Sargent,et al. Presence of fetal DNA in maternal plasma and serum , 1997, The Lancet.
[18] M. Egholm,et al. Peptide nucleic acid (PNA). A DNA mimic with a peptide backbone. , 1994, Bioconjugate chemistry.
[19] M. Egholm,et al. Single base pair mutation analysis by PNA directed PCR clamping. , 1993, Nucleic acids research.
[20] G. Saglio,et al. Prenatal diagnosis of fetal hemoglobin Lepore-Boston disease on maternal peripheral blood. , 1990, Blood.